Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Aerts

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Cancer Discovery|March 16, 2022
The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent MalignanciesPablo Berlanga, Gaelle Pierron, Ludovic Lacroix, et al.
Pediatric Blood & Cancer|November 19, 2024
Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France ExperiencePablo Berlanga, Isabelle Aerts, Nadège Corradini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2024
Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted TherapyCharles Bobin, Yasmine Iddir, Charlotte Butterworth, et al.
The Journal of Clinical Endocrinology and Metabolism|February 22, 2023
Assessment of Puberty and Hypothalamic-Pituitary-Gonadal Axis Function After Childhood Brain Tumor TreatmentManon Rosimont, Dulanjalee Kariyawasam, Dinane Samara-Boustani, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 2021
High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large CohortLaura Gabriela González Briceño, Dulanjalee Kariyawasam, Dinane Samara-Boustani, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortiumAlba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
JAMA Network Open|July 3, 2023
Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France StudyPablo Berlanga, Lee Aymar Ndounga-Diakou, Isabelle Aerts, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC studyFernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
JCO Precision Oncology|October 20, 2022
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility StudyOlivia Ruhen, Nathalie S M Lak, Janine Stutterheim, et al.
Science Translational Medicine|January 25, 2019
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01Guillem Pascual-Pasto, Miriam Bazan-Peregrino, Nagore G Olaciregui, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Cancer Discovery|March 16, 2022
The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent MalignanciesPablo Berlanga, Gaelle Pierron, Ludovic Lacroix, et al.
Pediatric Blood & Cancer|November 19, 2024
Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France ExperiencePablo Berlanga, Isabelle Aerts, Nadège Corradini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2024
Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted TherapyCharles Bobin, Yasmine Iddir, Charlotte Butterworth, et al.
The Journal of Clinical Endocrinology and Metabolism|February 22, 2023
Assessment of Puberty and Hypothalamic-Pituitary-Gonadal Axis Function After Childhood Brain Tumor TreatmentManon Rosimont, Dulanjalee Kariyawasam, Dinane Samara-Boustani, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 2021
High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large CohortLaura Gabriela González Briceño, Dulanjalee Kariyawasam, Dinane Samara-Boustani, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortiumAlba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
JAMA Network Open|July 3, 2023
Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France StudyPablo Berlanga, Lee Aymar Ndounga-Diakou, Isabelle Aerts, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC studyFernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
JCO Precision Oncology|October 20, 2022
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility StudyOlivia Ruhen, Nathalie S M Lak, Janine Stutterheim, et al.
Science Translational Medicine|January 25, 2019
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01Guillem Pascual-Pasto, Miriam Bazan-Peregrino, Nagore G Olaciregui, et al.
Pageof 13